The $147 billion U.S. pet care industry is undergoing a dramatic shift. As consumers move beyond basic nutrition and seek visible, condition-specific results, clinically validated postbiotics are emerging as a powerful new category. PetFoodConnect is helping supermarkets and mass retailers capitalize on this evolution through its turnkey private-label and licensing platform.

“Postbiotics aren’t just another SKU — they’re a category reset,” said Richard Gray, CEO of PetFoodConnect. “They allow retailers to deliver real, visible results like reduced itching, better stool consistency, and improved coat quality — all backed by published clinical data.”

Recent clinical outcomes include:

- 26% reduction in bad breath compounds within 7 days

- Up to 27% decrease in itching

- 11% improvement in coat quality

- Notable gains in stool consistency and microbiome richness

This next generation of pet wellness products has already surged to the top of Amazon’s pet category. Now, traditional retailers can move quickly to secure their market share. Through PetFoodConnect, partners can:

- Launch a private-label line of postbiotic formulas for oral, immune, and digestive health

- License either the Top Dog Chef or Dr. Jim's brands to enhance consumer trust and speed to shelf

- Bypass costly R&D while leveraging patent-pending IP and over $30 million in clinical investment

“Retailers who move first will own consumer trust and premium margins for years to come,” Gray added. “This is about delivering real results — not just repackaging old solutions.”

For further insight into the science and strategy behind the postbiotic movement, read the full blog post below: